China Digest: Medbanks nabs $59m Series D; Shenzhen Lihexing snags $19m

China Digest: Medbanks nabs $59m Series D; Shenzhen Lihexing snags $19m

T-lymphocytes attack a migrating cancer cell. Visual from Medisix's website.

China’s oncology database firm Medbanks Network Technology has raised $59 million in a Series D round while Shenzhen Lihexing has secured a funding of nearly $19 million.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter